@Ahmmm...!!

Monday, August 3, 2020

Serum gets DCGI nod for Phase 2 & 3 trials

India’s apex drug regulator has allowed Pune-based Serum Institute of India to conduct late-stage — Phase 2 and 3 — human trials in India for the Oxford University Covid-19 vaccine candidate.

from Times of India https://ift.tt/39ZeN7J
Share:

0 comments:

Post a Comment

Search This Blog

Powered by Blogger.

Definition List

Unordered List

Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.